Skip to main content
SpringerLink
Log in

Neurodevelopmental and associated changes in a patient with Xp22.31 duplication

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Li F, Shen Y, Köhler U, Sharkey FH, Menon D, Coulleaux L, Malan V, Rio M, McMullan DJ, Cox H, Fagan KA, Gaunt L, Metcalfe K, Heinrich U, Hislop G, Maye U, Sutcliffe M, Wu BL, Thiel BD, Mulchandani S, Conlin LK, Spinner NB, Murphy KM, Batista DAS (2010) Interstitial microduplication of Xp22.31: causative of intellectual disability or benign copy number variant? Eur J Med Genet 53:93–99

    Article  Google Scholar 

  2. Furrow A, Theisen A, Velsher L, Bawle EV, Sastry S, Mendelsohn NJ et al (2011) Duplication of the STS region in males is a benign copy-number variant. Am J Med Genet A 155A:1972–1975

    Article  Google Scholar 

  3. Liu P, Erez A, Nagamani SC, Bi W, Carvalho CM, Simmons AD et al (2011) Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Hum Mol Genet 20:1975–1988

    Article  Google Scholar 

  4. Esplin ED, Li B, Slavotinek A, Novelli A, Battaglia A, Clark R, Curry C, Hudgins L (2014) Nine patients with Xp22.31 microduplication, cognitive deficits, seizures, and talipes anomalies. Am J Med Genet A 164A:2097–2103

    Article  Google Scholar 

  5. Addis L, Sproviero W, Thomas SV, Caraballo RH, Newhouse SJ, Gomez K, Hughes E, Kinali M, McCormick D, Hannan S, Cossu S, Taylor J, Akman CI, Wolf SM, Mandelbaum DE, Gupta R, van der Spek RA, Pruna D, Pal DK (2018) Identification of new risk factors for rolandic epilepsy: CNV at Xp22.31 and alterations at cholinergic synapses. J Med Genet 55:607–616

    Article  CAS  Google Scholar 

  6. Liu P, Erez A, Nagamani SC, Bi W, Carvalho CM, Simmons AD et al (2011) Copy number gain at Xp22.31 includes complex duplicationrearrangements and recurrent triplications. Hum Mol Genet 20:1975–1988

    Article  Google Scholar 

  7. Sorokin A, Szekely A, Jabbari B (2013) Tremor as a prominent feature in Xp22.31 microduplication: a novel association. Neurology 80; supplement 7(p05.040)

  8. Pang T, Atefy R, Sheen V (2008) Malformations of cortical development. Neurologist 14:181–191

    Article  Google Scholar 

Download references

Acknowledgments

The present case report is dedicated to the memory of Dr. John Fernandes who was the primary pathologist contributing to this case report.

Author information

Authors and Affiliations

  1. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

    Christine MacColl & Jian-Qiang Lu

  2. Department of Radiology, McMaster University, Hamilton, Ontario, Canada

    Nina Stein

  3. Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada

    Nina Stein & Mark Tarnopolsky

  4. Department of Medicine/Neurology, McMaster University, Hamilton, Ontario, Canada

    Mark Tarnopolsky

  5. Neuropathology Section, Hamilton General Hospital, McMaster University, 237 Barton Street, Hamilton, Ontario, L8L 2X2, Canada

    Jian-Qiang Lu

Authors
  1. Christine MacColl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nina Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark Tarnopolsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jian-Qiang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian-Qiang Lu.

Ethics declarations

Conflict of interest

Dr. Mark Tarnopolsky is the CEO of Exerkine Corporation and the company is working on therapies that target mitochondrial dysfunction; the remaining authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

MacColl, C., Stein, N., Tarnopolsky, M. et al. Neurodevelopmental and associated changes in a patient with Xp22.31 duplication. Neurol Sci 41, 713–716 (2020). https://doi.org/10.1007/s10072-019-04065-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-04065-1

Search

Navigation